Stock GENIL GEN ILAC VE SAGLIK URUNLERI SANAYI VE TICARET ANONIM SIRKETI
Add to a list
To use this feature you must be a member
Log inSign up

Company Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi

Equities

GENIL

TREGENL00024

Pharmaceuticals

Delayed Borsa Istanbul
Other stock markets
 09:37:23 15/05/2024 BST 		5-day change 1st Jan Change
55.95 TRY +0.09% Intraday chart for Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi -5.73% +19.24%
04-06 Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Business Summary

Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS is a Turkey-based company, which engages in manufacturing of pharmaceuticals and other health products. The Company operates in the fields of manufacturing all kinds of pharmaceuticals for human use and health products, trading, import and export. Gen Ilac manufactures products used in the treatment of rare diseases and disorders in neurology, endocrinology, nephrology, oncology, hematology and pediatric branches. The Company has approximately 500 employees working in its production facilities on a closed area of 15,000 square meters, established on an area of approximately 43,000 square meters in Ankara ASO 2nd and 3rd Organized Industrial Zone. Entity has 5 offices abroad: Germany, Russia, Kazakhstan, Uzbekistan and Azerbaijan.

Number of employees: 622

Sales per Business

TRY in Million2022Weight2023Weight Delta
Human Pharmaceutical and Health Products Trading
100.0 %
5,445 100.0 % 8,152 100.0 % +49.70%

Sales per region

TRY in Million2022Weight2023Weight Delta
Turkey
127.6 %
2,060 37.8 % 10,403 127.6 % +404.99%
Sales Discounts
-32.5 %
-2,127 -39.1 % -2,651 -32.5 % +24.64%
Overseas
4.9 %
5,513 101.3 % 401 4.9 % -92.72%
Sales Returns
0.0 %
-2 0.0 % -2 0.0 % +23.17%

Managers

Managers TitleAgeSince
Nadir Ulu CTO
 Chief Tech/Sci/R&D Officer - 30/06/23
Ali Ketencioglu IRC
 Investor Relations Contact - 31/08/21
Selcuk Deniz Karagulle SAM
 Sales & Marketing - 31/07/10
Yagmur Gulmus PRN
 Corporate Officer/Principal - -

Members of the board

Members of the board TitleAgeSince
Abidin Gulmus CHM
 Chairman - -
Sukru Turkmen BRD
 Director/Board Member - -
Ömer Dinçer BRD
 Director/Board Member - -
Tolga Kiziltan BRD
 Director/Board Member - 30/03/22
Bernay Ozavci BRD
 Director/Board Member - 30/03/22

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 300,000,000 77,246,529 ( 25.75 %) 0 25.75 %

Shareholders

NameEquities%Valuation
Abidin Gulmus
73.22 %
219,660,000 73.22 % 372 M ₺
Semra Gulmus
1.250 %
3,750,000 1.250 % 6 M ₺
Sukru Turkmen
0.9020 %
2,706,000 0.9020 % 5 M ₺
Absel Ltd. Co.
0.4167 %
1,250,000 0.4167 % 2 M ₺
HSBC Portföy Yönetim AS
0.1667 %
500,000 0.1667 % 847 065 ₺
Cozum Ecza Deposu Medikal Ltd. Sti
0.0613 %
183,844 0.0613 % 311 456 ₺
State Street Global Advisors Ltd.
0.0536 %
160,711 0.0536 % 272 265 ₺
HSBC Asset Management (India) Pvt Ltd.
0.0437 %
131,000 0.0437 % 221 931 ₺
Erste Asset Management GmbH
0.0300 %
90,000 0.0300 % 152 472 ₺
AK Asset Management AS
0.0100 %
30,000 0.0100 % 50 824 ₺

Holdings

NameEquities%Valuation
JAGUAR HEALTH, INC.
6.03%
 16,666,666 6.03% 2,833,333 $

Company contact information

Gen Ilaç ve Saglik Ürünleri Sanayi ve Ticaret AS

Mustafa Kemal Mahallesi 2119. Sokak, 3-5

06510, Ankara

+90 312 219 62 19

http://www.genilac.com.tr
address Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi(GENIL)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
GEN ILAC VE SAGLIK URUNLERI SANAYI VE TICARET ANONIM SIRKETI Stock Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi
+19.24% 520M
NOVO NORDISK A/S Stock Novo Nordisk A/S
+31.89% 588B
JOHNSON & JOHNSON Stock Johnson & Johnson
-3.42% 364B
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.02% 326B
ABBVIE INC. Stock AbbVie Inc.
+4.27% 285B
ASTRAZENECA PLC Stock AstraZeneca PLC
+15.44% 239B
NOVARTIS AG Stock Novartis AG
+10.07% 210B
ROCHE HOLDING AG Stock Roche Holding AG
-6.91% 200B
AMGEN INC. Stock Amgen Inc.
+8.12% 167B
PFIZER, INC. Stock Pfizer, Inc.
-1.42% 161B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. GENIL Stock
  4. Company Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi